NCT00316537

Brief Summary

The purpose of this study is to evaluate the safety and preliminary efficacy of low dose nicotine gel in patients with chronic diabetic ulcers

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Oct 2006

Geographic Reach
1 country

13 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 17, 2006

Completed
4 days until next milestone

First Posted

Study publicly available on registry

April 21, 2006

Completed
5 months until next milestone

Study Start

First participant enrolled

October 1, 2006

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2007

Completed
Last Updated

August 9, 2007

Status Verified

August 1, 2007

First QC Date

April 17, 2006

Last Update Submit

August 7, 2007

Conditions

Keywords

diabetesfoot ulcersnicotine gelwound healing

Outcome Measures

Primary Outcomes (1)

  • Assessment of ulcer size as determined by weekly ulcer tracings

Secondary Outcomes (1)

  • Assessment for complete wound closure. "Complete wound closure" will be defined as full epithelialization of the wound with the absence of drainage and lack of dressing requirement for an interval of at least 2 weeks.

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with diabetes mellitus type II
  • Single non-healing uninfected partial or full-thickness foot ulcer secondary to diabetic neuropathy, in the absence of significant peripheral arterial disease.

You may not qualify if:

  • Patients who use tobacco in any form or who are on nicotine replacement therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

SeniorCare, Alabama Geriatric Specialists

Homewood, Alabama, 35209, United States

Location

Hope Research Institute

Phoenix, Arizona, 85050, United States

Location

Southern Arizona VA Health Care System

Tucson, Arizona, 85723, United States

Location

Center for Clinical Research

Castro Valley, California, 94546, United States

Location

University of San Diego Wound Treatment and Research Center

San Diego, California, 92103, United States

Location

University of Miami

Miami, Florida, 33136, United States

Location

Ankle and Foot Specialists of Atlanta

Lithonia, Georgia, 30058, United States

Location

Crossroads Research, Inc.

Owings Mills, Maryland, 21117, United States

Location

Beth Israel Deaconess Medical Center

Boston, Massachusetts, 02215, United States

Location

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location

NewBridge Medical Research

Warren, Pennsylvania, 16365, United States

Location

Central Washington Podiatry Service

Yakima, Washington, 98902, United States

Location

Aurora Health Care / Lukes Medical Center

Milwaukee, Wisconsin, 53215, United States

Location

MeSH Terms

Conditions

Diabetic FootDiabetes MellitusFoot Ulcer

Interventions

Drug Evaluation

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsEndocrine System DiseasesDiabetic NeuropathiesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesFoot Diseases

Intervention Hierarchy (Ancestors)

Drug DevelopmentInvestigative TechniquesEvaluation Studies as Topic

Study Officials

  • Henry Hsu, MD

    Athenagen, Inc.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

April 17, 2006

First Posted

April 21, 2006

Study Start

October 1, 2006

Study Completion

July 1, 2007

Last Updated

August 9, 2007

Record last verified: 2007-08

Locations